StonvexLoading…
StonvexStonvexStonvexCore line items from VRM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2023 2023-12-31 | Q3 2023 2023-09-30 | Q2 2023 2023-06-30 | Q1 2023 2023-03-31 |
|---|---|---|---|---|
Revenue | $893.20M | $657.28M | $421.64M | $196.47M |
Operating Income | $0.00 | $-163.38M | $-120.87M | $-68.26M |
Net Income | $-364.61M | $-223.51M | $-66.04M | $-74.74M |
EPS (Diluted) | $-209.17 | $-128.52 | $-81.12 | $-43.16 |
Total Assets | $1.48B | $1.65B | $1.59B | $1.65B |
Total Liabilities | $1.35B | $1.39B | $1.25B | $1.25B |
Cash & Equivalents | $135.59M | $208.56M | $237.93M | $316.71M |
Free Cash Flow OCF − CapEx | $-536.31M | $-427.56M | $-233.37M | $-85.83M |
Shares Outstanding | 1.79M | 139.75M | 139.65M | 138.80M |